Copeland Capital Management LLC lowered its holdings in Cabot Corporation (NYSE:CBT – Free Report) by 8.2% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 739,690 shares of the specialty chemicals company’s stock after selling 65,814 shares during the quarter. Copeland Capital Management LLC’s holdings in Cabot were worth $55,477,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. LSV Asset Management raised its holdings in Cabot by 318.0% during the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock valued at $47,476,000 after acquiring an additional 434,434 shares during the period. American Century Companies Inc. grew its position in shares of Cabot by 13.2% in the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock valued at $124,566,000 after purchasing an additional 174,921 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of Cabot by 79.5% during the 1st quarter. AQR Capital Management LLC now owns 389,244 shares of the specialty chemicals company’s stock valued at $31,626,000 after purchasing an additional 172,410 shares during the period. Nuveen LLC purchased a new stake in Cabot during the 1st quarter worth about $12,365,000. Finally, GAMMA Investing LLC boosted its stake in Cabot by 10,385.0% in the 1st quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company’s stock worth $11,751,000 after purchasing an additional 139,990 shares during the period. 93.18% of the stock is owned by institutional investors.
Analyst Ratings Changes
Separately, UBS Group set a $82.00 price target on shares of Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Cabot presently has an average rating of “Hold” and a consensus price target of $92.33.
Cabot Price Performance
Cabot stock opened at $75.60 on Friday. The business has a 50-day simple moving average of $78.24 and a 200 day simple moving average of $77.67. Cabot Corporation has a 52 week low of $70.40 and a 52 week high of $117.46. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 9.88 and a beta of 0.88. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The firm had revenue of $923.00 million during the quarter, compared to the consensus estimate of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, research analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.
Cabot Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, September 11th. Shareholders of record on Friday, August 29th were paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Friday, August 29th. Cabot’s payout ratio is currently 23.53%.
Insider Activity at Cabot
In other news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 3.03% of the stock is owned by insiders.
Cabot Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Read More
- Five stocks we like better than Cabot
- Where to Find Earnings Call Transcripts
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Insider Trades May Not Tell You What You Think
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- High Flyers: 3 Natural Gas Stocks for March 2022
- NVIDIA Breaks Out to New Highs: What Comes Next?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.